Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor CellsDominique Verhelle, Kyle Chan, Helen Brady et al.|Cancer Research|2007Cited by 232
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cellsLaure A Moutouh-de Parseval, Kyle Chan, Dominique Verhelle et al.|Journal of Clinical Investigation|2008Cited by 180
Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.Laure Moutouh de Parseval, Kyle Chan, Helen Brady et al.|Blood|2005Cited by 3
284 POSTER Lenalidomide and CC-4047 inhibit the proliferation of Namalwa cancer cells while expanding CD34+ progenitor cells. New insights on the combination therapy with HDAC inhibitors for hematological cancersDominique Verhelle, Kyle Chan, Laura G. Corral et al.|European Journal of Cancer Supplements|2006Cited by 0
New Approaches to the Regulation of Erythropoiesis and Hematoglobin Synthesis in β-Hemoglobinopathies: Studies with the Immunomodulatory Drug CC-4047.Laure A. Moutouh de Parseval, Kyle Chan, Dominique Verhelle et al.|Blood|2006Cited by 0